Lymphoedema management – Procedures on the treated side

Recommendation

Lymphoedema management – Procedures on the treated side

Low risk medical procedures (such as injections, blood tests, or intravenous administration of medicines) can be performed on the arm of the treated side if needed, as such procedures will not cause or worsen lymphoedema. In patients with lymphoedema, blood pressure monitoring on the arm of the treated side should depend on clinical need.

How this guidance was developed

This recommendation was adapted from the NICE 2018 guidelines (UK). The source recommendation was based on a systematic review of the evidence conducted in September 2017. The strength of the recommendation could not be determined from the wording and is more of an evidence statement. The adaption clarified that low risk medical procedures can be performed on the affected side without fear of causing or worsening lymphoedema. It was acknowledged that there is insufficient evidence to support or not support blood pressure monitoring of the treated arm, hence the decision should be based on clinical need.

Lymphoedema management – Procedures on the treated side

Recommendation

Low risk medical procedures (such as injections, blood tests, or intravenous administration of medicines) can be performed on the arm of the treated side if needed, as such procedures will not cause or worsen lymphoedema. In patients with lymphoedema, blood pressure monitoring on the arm of the treated side should depend on clinical need.

Principles in action
Image
Safe and quality care
Image
Supportive care
Image
Communication

This recommendation was adapted from the NICE 2018 guidelines (UK). The source recommendation was based on a systematic review of the evidence conducted in September 2017. The strength of the recommendation could not be determined from the wording and is more of an evidence statement. The adaption clarified that low risk medical procedures can be performed on the affected side without fear of causing or worsening lymphoedema. It was acknowledged that there is insufficient evidence to support or not support blood pressure monitoring of the treated arm, hence the decision should be based on clinical need.